The dual role of mir-146a in metastasis and disease progression

Alipour Shahriar1, Gholizadeh Ghaleh-Aziz Shiva1, Babaei Ghader1

  • 1Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Abstract

Insights

MicroRNA 146a (miR146a) plays a dual role in cancer metastasis and regulates inflammatory genes, offering therapeutic potential. Understanding miR146a regulation enhances insights into inflammatory diseases and cancers.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • MicroRNAs (miRNAs) are endogenous non-coding RNAs regulating gene expression post-transcriptionally.
  • miR146a is a key regulator of inflammatory responses and innate immunity.
  • Dysregulation of miR146a is implicated in various diseases, including cancer.

Purpose of the Study:

  • To systematically review the role of miR146a in immune system regulation and tumorigenesis.
  • To investigate miR146a's impact on signaling pathways relevant to cancer and immunity.
  • To explore therapeutic strategies involving miR146a.

Main Methods:

  • Systematic literature search of MEDLINE, Web of Science, and Cochrane Library.
  • Inclusion of comparative studies published in English from 2000 to 2019.

Main Results:

  • miR146a exhibits a dual role in cancer cell metastasis, acting as both an inhibitor and stimulator.
  • miR146a influences inflammatory and anti-inflammatory gene expression.
  • Therapeutic potential of miR146a demonstrated through its effects on NF-kB, SIRT1, TNF-α, and IL-1β.

Conclusions:

  • Alterations in miR146a regulation provide insights into the molecular basis of chronic inflammatory diseases.
  • Understanding miR146a is crucial for developing novel therapeutic approaches for cancers and inflammatory conditions.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K